Nature, in its intricate design, has bestowed upon us a hidden arsenal in the form of antimicrobial peptides (AMPs) – small, naturally occurring molecules that play a pivotal role in the innate immune response of various organisms. These peptides, a product of millions of years of evolutionary refinement, possess remarkable antimicrobial properties, challenging the traditional paradigms of antibiotic development. AMPs act as nature's guardians, defending against invading pathogens with a multifaceted approach. They disrupt microbial cell membranes, target intracellular components, and even modulate immune responses. Their versatility and ability to combat a broad spectrum of microorganisms make them promising candidates for novel antimicrobial therapies. Scientists are unraveling the secrets of AMPs, seeking inspiration for the development of synthetic counterparts. By understanding the structural motifs and mechanisms of action employed by these peptides, researchers aim to design antimicrobial agents that mimic nature's elegance. This approach holds the potential to overcome the challenges posed by antibiotic resistance, as AMPs present a unique strategy that bacteria are less likely to develop resistance against.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain